A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment

K. Burnett, Alan; Milligan, Donald; G. Prentice, Archie; H. Goldstone, Anthony; F. McMullin, Mary; K. Hills, Robert; Wheatley, Keith

doi:10.1002/cncr.22496

Public

A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment

Shared by NobleBlocks on Feb 21, 2007 • 12:00 AM UTC

Authors:

Alan K. Burnett

Donald Milligan

Archie G. Prentice

Abstract

Abstract BACKGROUND The survival of older patients with acute myeloid leukemia has not improved. Few clinical trials have been available for older patients who are not considered fit for an intensive chemotherapy approach. METHODS Between December 1998 and November 2003, as part of National Cancer R...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!